Page 573 - Multidisipliner Covid 19

COVID-19 Pandemisi ve Kalp-Damar Sistemi

41. Wu Z, McGoogan JM. Characteristics of and Important Lessons From
the Coronavirus Disease 2019 (COVID-19) Outbreak inChina: Sum-
mary of a Report of 72 314 Cases From the Chinese Center for Dis-
ease Control and Prevention. JAMA 2020 Feb 24.Epub ahead of print],
doi: 10.1001/jama.2020.2648.
42. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA,
Solomon SD. Renin-Angiotensin-Aldosterone System Inhibitorsin
Patients with Covid-19. N Engl J Med 2020;382:1653–9.
43. Simone G, Mancusi C. Speculation is not evidence: antihypertensive
therapy and COVID-19. Eur Heart J Cardiovasc Pharmacother2020
Apr 1. [Epub ahead of print], doi: 10.1093/ehjcvp/pvaa021.
44. Patel AB, Verma A. COVID-19 and Angiotensin-Converting Enzyme
Inhibitors and Angiotensin Receptor Blockers: What Is theEvidence?
JAMA 2020 Mar 24. [Epub ahead of print], doi: 10.1001/jama.2020.4812.
45. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next?. Lancet
2020; 395: 1225–8.
46. Henry C, Zaizafoun M, Stock E, Ghamande S, Arroliga AC, White
HD. Impact of angiotensin-converting enzyme inhibitors andstatins
on viral pneumonia. Proc (Bayl Univ Med Cent) 2018;31:419–23.
47. Aktoz M, Altay H, Aslanger E, Atalar E, Aytekin V, Baykan AO, et al.
Consensus Report from Turkish Society of Cardiology: COVID-19
and Cardiovascular Diseases. What cardiologists should know. (25th
March 2020). [Article in Turkish] Turk Kardiyol DernArs 2020;48:1–48.
48. ESH UPDATE ON COVID-19. European Society of Hypertension.
Available at: https://www.eshonline.org/spotlights/esh-stabtement-
on-covid-19-2/. 2020.Accessed Mar 27
49. UPDATED-COVID-19 and concerns regarding use of cardiovascular
medications, including ACEi/ARB/ARNi, low-dose ASA andnon-
steroidal anti-inflammatory drugs (NSAIDS). Available at: https://
twitter.com/WHO/status/1240409217997189128?s=20. 2020.Accessed
Mar 27
50. Position Statement of the ESC Council on Hypertension on ACE-In-
hibitors and Angiotensin Receptor Blockers. Available at: https://www.
escardio.org/Councils/Council-on-Hypertension-(CHT)/News/
position-statement-of-the-esc-council-on-hypertension-on-aceinhibi-
tors-and-ang. 2020.Accessed Mar 27
51. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angi-

572